|
^* EPYSQLI(®) (eculizumab-aagh) is now available to patients living with
difficult-to-treat rare diseases… |
|
^* If approved for an expanded pediatric indication, AJOVY would be the first
… |
|
^* More than 92% of schizophrenia patients taking TEV-'749 in the SOLARIS
survey… |
|
^TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical
Industries Ltd. (NYSE and TASE: TEVA)… |
|
^TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical
Industries Ltd. (NYSE and TASE: TEVA)… |
| TEL AVIV, Israel, March 27, 2025 (GLOBE NEWSWIRE) -- Teva Pharmaceutical Industries Ltd. (NYSE and TASE: TEVA) announced… |